The transition period — the three weeks before and three weeks after calving — represents the highest-risk welfare window in the dairy cow's production cycle. Metabolic diseases, immune dysfunction, and negative energy balance converge during this time, with consequences for both immediate welfare and long-term health and productivity. Evidence-based transition management is the single most impactful management area for dairy welfare.
Why Transition is High-Risk
The transition from non-lactating to lactating creates profound physiological stress:
- Dramatic increase in nutrient demands at lactation onset exceeds nutrient intake capacity
- Negative energy balance (NEB) drives fat mobilisation, generating NEFAs and ketone bodies
- Immune function is naturally suppressed around calving (periparturient immune suppression) increasing infection susceptibility
- Calcium homeostasis is disrupted — hypocalcaemia affects muscle function, including the uterus and rumen
- Social and dietary changes from moving cows through pen sequences add further stress
Metabolic Diseases of Transition
Subclinical ketosis: Affects 25–40% of cows in the first 2 weeks of lactation; blood BHB ≥1.2 mmol/L; reduces milk yield, fertility, and immune function; increases risk of metritis and mastitis.
Hypocalcaemia (milk fever): Affects 5–10% of cows clinically, with subclinical prevalence much higher; causes muscle weakness, recumbency, and metabolic cascade including reduced rumination, displacement of abomasum, and immune suppression.
Displaced abomasum (DA): Right or left displacement; surgical correction required; associated with ketosis and hypocalcaemia predisposing to gut hypomotility.
Metritis: Uterine infection in the first 3 weeks after calving; profound systemic illness in severe cases; linked to immune suppression from NEB and hypocalcaemia.
Management Principles
Body condition at dry-off: Target BCS 3.0–3.25 — over-fat cows (BCS >3.75) mobilise excessive fat reserves postpartum, generating more NEFAs and increasing disease risk dramatically.
Pre-calving nutrition: Controlled energy diets (straw-based or negative DCAB) in the close-up period (−3 weeks to calving) limit fat accumulation while providing adequate minerals and vitamins.
Post-calving monitoring: Blood ketone testing (Precision Xtra) at days 3–5 and 7–10; propylene glycol treatment for subclinical ketosis; calcium supplementation protocols for high-risk cows.
Pen management: Minimising pen moves during the transition period; adequate feed bunk space (1:1 cow:space minimum); low-stress introduction to fresh cow groups.
Return on Investment
Investment in transition management consistently shows positive returns: each case of metritis costs approximately £200–300; each DA case approximately £500–800 in surgery and production loss; each case of clinical ketosis approximately £200. Reducing transition disease rates by 50% in a 200-cow herd saves £30,000–50,000 annually while dramatically improving individual cow welfare.